http://researchonline.federation.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 Effect of hydralazine on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein e-deficient mice http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:19126 Tue 26 Mar 2024 15:08:11 AEDT ]]> A modified MTS proliferation assay for suspended cells to avoid the interference by hydralazine and β-Mercaptoethanol http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:15171 Mon 13 Sep 2021 17:28:12 AEST ]]> Moxonidine increases uptake of oxidised low-density lipoprotein in cultured vascular smooth muscle cells and inhibits atherosclerosis in apolipoprotein E-deficient mice http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:18186 Mon 11 Sep 2023 10:11:40 AEST ]]> An improved 3-(4,5-dmethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl )-2H-tetrazolium proliferation assay to overcome the interference of hydralazine http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:15089 = 10 mu M) increased absorbance in a concentration-dependent manner. The modified MTS assay produced results consistent with trypan blue exclusion and microscopy. In conclusion, a simple modification of the standard MTS assay overcame the interference of hydralazine and may be useful to avoid interference from other tested compounds.]]> Mon 10 Jan 2022 15:16:15 AEDT ]]>